ESTABLISHMENT OF SORAFENIB-RESISTANT MOUSE RENAL CELL CARCINOMA RENCA CELLS AND CHARACTERIZATION OF THEIR ACQUIRED RESISTANT MECHANISM

被引：0
|
作者：
Kusuda, Yuji
Miyake, Hideaki
Sakai, Iori
Fujisawa, Masato
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
299
引用
收藏
页码：E121 / E121
页数：1
相关论文
共 50 条
  • [31] Potential Therapeutic Agents against Paclitaxel-And Sorafenib-Resistant Papillary Thyroid Carcinoma
    Kim, Seok-Mo
    Park, Keunwan
    Lim, Jin Hong
    Yun, Hyeok Jun
    Kim, Sang Yong
    Choi, Kyung Hwa
    Kim, Chan Wung
    Lee, Jae Ha
    Weicker, Raymond
    Pan, Cheol-Ho
    Park, Ki Cheong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [32] Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells
    Hong, Tae Ho
    Jeena, M. T.
    Kim, Ok-Hee
    Kim, Kee-Hwan
    Choi, Ho Joong
    Lee, Kyung Hee
    Hong, Ha-Eun
    Ryu, Ja-Hyoung
    Kim, Say-June
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [33] Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells
    Tae Ho Hong
    M. T. Jeena
    Ok-Hee Kim
    Kee-Hwan Kim
    Ho Joong Choi
    Kyung Hee Lee
    Ha-Eun Hong
    Ja-Hyoung Ryu
    Say-June Kim
    Scientific Reports, 11
  • [34] Antitumor activity of lenvatinib in the renal cell carcinoma cell line RENCA model resistant to a VEGF specific inhibitor
    Ichikawa, Kenji
    Miyano, Saori Watanabe
    Minoshima, Yukinori
    Matsui, Junji
    CANCER RESEARCH, 2018, 78 (13)
  • [35] Targeting sorafenib-resistant HCCs by protein X-armed T cell immunotherapy
    Mai-Huong Thi Ngo
    Chen, Michael
    Lan, Pei-Chi
    Chuang, Kuo-Hsiang
    Huang, Yen-Hua
    CANCER RESEARCH, 2024, 84 (06)
  • [36] Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma
    Chang, Hang-Seok
    Kim, Yonjung
    Lee, So Young
    Yun, Hyeok Jun
    Chang, Ho-Jin
    Park, Ki Cheong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [37] Metabolic implication of tigecycline as an efficacious second-line treatment for sorafenib-resistant hepatocellular carcinoma
    Messner, Martina
    Schmitt, Sabine
    Ardelt, Maximilian A.
    Froehlich, Thomas
    Mueller, Martin
    Pein, Helmut
    Huber-Cantonati, Petra
    Ortler, Carina
    Koenig, Lars M.
    Zobel, Lena
    Koeberle, Andreas
    Arnold, Georg J.
    Rothenfusser, Simon
    Kiemer, Alexandra K.
    Gerbes, Alexander L.
    Zischka, Hans
    Vollmar, Angelika M.
    Pachmayr, Johanna
    FASEB JOURNAL, 2020, 34 (09): : 11860 - 11882
  • [38] Sorafenib-Resistant Hepatocellular Carcinoma Stratified by Phosphorylated ERK Activates PD-1 Immune Checkpoint
    Chen, Jiang
    Ji, Tong
    Zhao, Jie
    Li, Gaofeng
    Liang, Xiao
    Xie, Anyong
    Lin, Hui
    Cang, Yong
    Cai, Xiujun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (01) : 152 - +
  • [39] High spatiotemporal heterogeneity, clonal selection and neoantigen evolution in acquired sorafenib-resistant patient-derived xenograft models of hepatocellular carcinoma.
    Yang, Xin-Rong
    Hu, Bo
    Zhou, Wan
    Fan, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells
    Xu, Gui-Li
    Ni, Cai-Fang
    Liang, Han-Si
    Xu, Yun-Hua
    Wang, Wan-Sheng
    Shen, Jian
    Li, Ming-Ming
    Zhu, Xiao-Li
    GASTROENTEROLOGY REPORT, 2020, 8 (05): : 390 - 398
12345